(3R)-HYDROXYACYL-ACP DEHYDRATASE ENZYMES USED IN THE BIOSYNTHESIS OF MYCOLIC ACIDS AND USE OF SAME FOR SCREENING ANTIBIOTICS
申请人:Quemard Annaik
公开号:US20100143940A1
公开(公告)日:2010-06-10
The invention relates to (3R)-hydroxyacyl-ACP dehydratase enzymes involved in the biosynthesis of mycolic acids, and to the use of same for screening antibiotics, medicaments that can be used to treat infections in humans or in animals, caused by
Corynebacterineae
, more specifically infections caused by pathogenic mycobacteria (
Mycobacterium tuberculosis, M. africanum, M. leprae, M. ulcerans, M. microti, M. bovis, M. abscissus, M. avium, M. fortuitum, M. kansasii
. . . ), and infections caused by other genera such as
Nocardia, Rhodococcus, Gordona . . .
本发明涉及参与肌酸酰基载体脱水酶酶的生物合成的3R-羟基酰基-ACP脱水酶酶,以及将其用于筛选抗生素、治疗人类或动物感染的药物,这些感染是由科林氏杆菌科引起的,更具体地说是由致病性分枝杆菌(结核分枝杆菌、非洲结核分枝杆菌、麻风分枝杆菌、溃疡分枝杆菌、小鼠结核分枝杆菌、牛分枝杆菌、阿布西斯分枝杆菌、鸟分枝杆菌、偶然分枝杆菌、堪萨斯分枝杆菌等)和其他属(如诺卡氏菌、红球菌、戈多纳菌等)引起的感染。